Report post
Catalyst Biosciences is aiming to revolutionize drug therapy by reducing dosage amounts. The company's CMO discusses the current state of hemophilia and how Catalyst's innovative approach can make a difference. Learn more about Catalyst Biosciences Inc.'s NASDAQ-listed CBIO stock, including trading facts and the latest news. Stay informed with our up-to-date coverage on CBIO stock.

The World's Leading Crypto Trading Platform

Get my welcome gifts